sec filing
IN
NASDAQ · INMB
INmune Bio, Inc.
Healthcare · Biotechnology
$2.32
Up+$0.16 (+7.41%)
Updated Aug 22, 2026, 7:43 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 56.63M
- P/E ratio
- -1.14
- Dividend yield
- 0.00%
- 52-week range
- $1.09 – $2.34
- Volume
- 520.14K
- Avg. volume
- 455.95K
Price performance
INMB price history
1M range · 21 trading sessions · Daily adjusted prices
INMB closed at $2.32 after 21 trading sessions, up 43.21% for the selected period.
- Last close
- $2.32
- Period change
- +43.21%
- Period low
- $1.62
- Period high
- $2.32
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $2.22 | $2.341 | $2.19 | $2.32 | 520.14K |
| Aug 20, 2026 | $2.20 | $2.24 | $2.145 | $2.16 | 393.67K |
| Aug 19, 2026 | $2.17 | $2.27 | $2.13 | $2.23 | 437.07K |
| Aug 18, 2026 | $2.09 | $2.18 | $2.08 | $2.11 | 231.19K |
| Aug 17, 2026 | $2.17 | $2.195 | $2.105 | $2.13 | 257.53K |
| Aug 14, 2026 | $2.09 | $2.20 | $2.04 | $2.17 | 462.03K |
| Aug 13, 2026 | $2.05 | $2.125 | $2.03 | $2.08 | 208.58K |
| Aug 12, 2026 | $2.08 | $2.106 | $2.01 | $2.04 | 352.1K |
| Aug 11, 2026 | $2.06 | $2.12 | $2.01 | $2.08 | 436.63K |
| Aug 10, 2026 | $2.10 | $2.195 | $2.05 | $2.12 | 462.84K |
| Aug 7, 2026 | $1.97 | $2.105 | $1.92 | $2.085 | 953.03K |
| Aug 6, 2026 | $1.86 | $1.94 | $1.84 | $1.91 | 244.6K |
| Aug 5, 2026 | $1.95 | $1.9599 | $1.79 | $1.90 | 491.22K |
| Aug 4, 2026 | $1.88 | $1.95 | $1.855 | $1.91 | 414.34K |
| Aug 3, 2026 | $1.77 | $1.8697 | $1.72 | $1.85 | 222.9K |
| Jul 31, 2026 | $1.77 | $1.79 | $1.715 | $1.75 | 225.76K |
| Jul 30, 2026 | $1.70 | $1.78 | $1.69 | $1.77 | 134.24K |
| Jul 29, 2026 | $1.72 | $1.82 | $1.68 | $1.69 | 217.45K |
| Jul 28, 2026 | $1.74 | $1.771 | $1.66 | $1.71 | 130.86K |
| Jul 27, 2026 | $1.63 | $1.75 | $1.63 | $1.73 | 180.53K |
| Jul 24, 2026 | $1.69 | $1.71 | $1.61 | $1.62 | 186.1K |
Latest INMB news
The latest Smart Investors Daily articles mentioning INMB.
Stock researchCompany · Financials
Loading stock research…

